MACRAMÉ Partner Spotlight: Epithelix
Epithelix (www.epithelix.com) is a pioneering biotechnology company specialized in tissue engineering and in vitro respiratory disease modelling.
Epithelix (www.epithelix.com) is a pioneering biotechnology company specialized in tissue engineering and in vitro respiratory disease modelling.
With the expertise brought together in MACRAMÉ and the experiences gained throughout the project duration, MACRAMÉ responded to the call for evidence to the Advanced Materials Act.
The ‘Joint Risk Assessor Summit on Advancing Safety & Sustainability Assessments of Advanced Materials’ hosted at the Organisation for Economic Cooperation and Development (OECD) in Paris and co-organised by four Horizon Europe projects ACCORDs, iCARE, MACRAMÉ, and nanoPASS, was a full success. Now, the full report of the event is available.
The Horizon Europe projects MACRAMÉ, iCARE, nanoPASS and DESIDERATA jointly organised an exclusive two-day virtual workshop advancing the harmonization and standardization of testing methodologies for nanomaterials and advanced materials.
Advanced materials bring new challenges for safety and sustainability assessment. To address these, the EU Horizon Europe projects iCare, MACRAMÉ, and nanoPASS are hosting a Joint Summit to address the needs of industry and regulators in assessing the safety and sustainability of advanced materials. …
MACRAMÉ colleagues from AcumenIST and University of Birmingham have contributed to a publication that provides insights into the technical and organisational challenges to the practical implementation of the SSbD, and future financial directions in supporting and maintaining the digital products currently under development within the H2020 projects.